The launch of a 750mcg PTH injection in Australia has been somewhat restricted , with availability primarily via specialist clinicians and designated clinics . Preliminary sales figures for this higher dosage remain confidential from the supplier , although industry sources suggest moderate adoption rates . Distribution to individuals is dictated b